Salvia BioElectronics receives FDA Breakthrough Device Designation for innovative neurostimulation solution ...Middle East

EINDHOVEN, Netherlands, Nov. 3, 2020 /PRNewswire/ -- Salvia BioElectronics B.V. ("Salvia"), a neurostimulation platform company targeting chronic migraine, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its implantable...

Read More Details
Finally We wish PressBee provided you with enough information of ( Salvia BioElectronics receives FDA Breakthrough Device Designation for innovative neurostimulation solution )

Also on site :

• Possible tornado in Phelps on Monday
• Bagel Land in Brighton temporarily closed due to sanitary code violation
• Meta reportedly recruits Apple’s head of AI models